Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CRISPR_RSL

ABSTRACT: CRISPR/Cas9 screening using unique molecular identifiers

PROVIDER: PRJEB18436 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2114695.fastq.gz	Fastqsanger.gz
	ERR2114696.fastq.gz	Fastqsanger.gz
	ERR2114697.fastq.gz	Fastqsanger.gz
	ERR2114698.fastq.gz	Fastqsanger.gz
	ERR2114699.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Project description:Digital RNA sequencing using unique molecular identifiers

| PRJNA967219 | ENA

Project description:Digital sequencing using structured unique molecular identifiers

| PRJNA844028 | ENA

Counting absolute number of molecules using unique molecular identifiers

Project description:Counting absolute number of molecules using unique molecular identifiers

| PRJEB2713 | ENA

Genotyping of C.elegans mutants - CRISPR/Cas9 of all GPCR and neuropeptide genes

Project description:CRISPR/Cas9 genome editing was used to disrupt nearly all the GPCR and neuropeptide genes from C. elegans genome. Multiple genes were disrupted in each strain for the purpose of screening. The genotype is the list of targeted genes

2023-06-02 | E-MTAB-12983 | biostudies-arrayexpress

Amplicon sequencing of fungicide resistance target genes

Project description:Amplicon sequencing of Cyp51 from a fungal pathogen using unique molecular identifiers

| PRJEB64200 | ENA

Genome-wide identification of CRISPR/Cas9 off-targets in human genome

Project description:By a robust unbiased ChIP-seq approach, we demonstrated that CRISPR/Cas9 had crRNA-specific off-target binding activities in human genome. However, most of those binding off-targets could not be efficiently cleaved both in vivo and in vitro which suggested the cleavage off-target activity of CRISPR/Cas9 in human genome is very limited. We provided a valuable tool to further investigate the molecular mechanism of CRISPR/Cas9 and to optimize its in vivo targeting sgRNA binding sites were identified with ChipSeq by using GFP antibody (there are 2 replicates for egfa-t1 sgRNA,emx1 sgRNA and control without sgRNA in Hek293T cells, one egfa-t1 sgRNA,emx1 sgRNA and control without sgRNA in HeLaS3 cells)

2014-06-18 | E-GEOD-58511 | biostudies-arrayexpress

Project description:MTMCT CRISPR-Cas9 screening

| PRJNA1255442 | ENA